Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-06-14

Clinical Trial Update: Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension

View source ↗

Summary

Clinical trial update on amyloid prediction in early-stage Alzheimer's disease through speech phenotyping (FUTURE Extension) indicates the study has been termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Novoic Limited | Conditions: Alzheimer Disease, Preclinical Alzheimer's Disease | Status: TERMINATED